Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 463 | 510 | 15 | 3 | 4 |
| TOTAL | $463 | $514 | $15 | $3 | $4 |
| Non-Current Assets | |||||
| Intangibles | 152 | 145 | 142 | 144 | 132 |
| TOTAL | $152 | $145 | $142 | $144 | $132 |
| Total Assets | $615 | $659 | $156 | $148 | $136 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50 | 50 | 50 | 38 | 48 |
| Accounts payable and accrued liabilities | 2,290 | 1,893 | 1,687 | 1,214 | 971 |
| Other current liabilities | 1,865 | 502 | 519 | 726 | 1,020 |
| TOTAL | $5,010 | $3,250 | $3,061 | $2,783 | $2,844 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,010 | $3,250 | $3,061 | $2,783 | $2,844 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,195 | 113,362 | 99,104 | 88,992 | 88,992 |
| Common Shares | 113 | 108 | 89 | 89 | 89 |
| Retained earnings | -23,113 | -21,044 | -20,522 | -20,239 | -20,275 |
| Other shareholders' equity | 0 | 0 | 13 | 0 | 0 |
| TOTAL | $-4,395 | $-2,591 | $-2,905 | $-2,635 | $-2,708 |
| Total Liabilities And Equity | $615 | $659 | $156 | $148 | $136 |